Water-based cannabinoid and opioid compositions
AssigneeDay Three Labs Manufacturing Inc.
InventorsWilliam Z. Levine, Shmuel Cohen
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention relate to methods for the manufacture of a protein-bound cannabinoid, comprising: obtaining a cannabinoid or cannabis in a form selected from the group consisting of cannabis smoke, cannabis vapor, cannabinoid solution and cannabis extract, and combining the cannabis smoke, vapor, cannabinoid solution or cannabis extract with an aqueous solution or suspension comprising a plasma protein to form a protein-bound cannabinoid. Further embodiments relate to aqueous solutions comprising a plasma protein-bound cannabinoid and pharmaceutical compositions comprising cannabinoids bound to plasma protein.
Claims14
A method of treating attention deficit disorder in a human suffering from attention deficit disorder consisting essentially of administering to the human in need thereof a cannabinoid bound to a protein selected from the group consisting of:
- albumin, α globulin, β globulin, and γ globulin to effectively treat the attention deficit disorder in the human in need thereof.
Dependencies are inferred from the claim text.